SSII

SS Innovations International Inc. Common Stock (SSII)

Stock · NASDAQ · Health Care

$2.53as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

SSII Submits FDA Response for SSi Mantra Robotic System. SS Innovations International has submitted a response to the FDA regarding its 510(k) submission for the SSi Mantra surgical robotic system. This regulatory update addresses a request for additional information, marking a step in the approval process for the company's key product. Separately, Zacks initiated coverage of the stock with a neutral recommendation.

Active signals

Resistance level
$3.49
Industry
Medical/Dental Instruments

What SSII's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike14-0.5%50%
Bollinger Band Breakdown7-2.4%43%
Bollinger Band Breakout5-18.9%20%
Any 20-session window (baseline)-5.6%38%

Computed by MarketWall from daily closing prices since May 23, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SSII

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NAD…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
483

Fundamentals

1-day range
$2.43$2.75
Market cap
$742.49M
P/E (trailing)
—
P/E (forward)
-42.50
EPS (trailing)
$-0.06
Dividend yield
—
Beta
-82.99
Avg. volume
63.7K
52-week range
$2.57$10
Next earnings: August 11, 2026 · EPS estimate $-0.01confirmed

How SS Innovations International Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$42.48MCost of Revenue$22.94M (54%)SG&A$14.85M (35%)Tax$3.97M (9%)R&D$3.69M (9%)SSII

Source: 10-K filed Mar 10, 2026 · via SEC EDGAR / Finnhub

Gross Profit$19.54M(46%)
Operating Income-$8.19M(-19%)

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$7
+176.7%
Median
$7
+176.7%
Low
$7
+176.7%

SS Innovations International Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • SSII
    SS Innovations International Inc. Common Stock
    $2.53
    ▼ 1.94%
    Market cap $742.49MP/E —
    $2.57$10
  • SIBN
    SI-BONE Inc. Common Stock
    $19.68
    ▼ 1.16%
    Market cap $813.01MP/E —
    $11.48$21.89
  • SGP
    SpyGlass Pharma Inc. Common Stock
    $24
    ▼ 2.91%
    Market cap $827.48MP/E —
    $17.06$32.44
  • TCMD
    Tactile Systems Technology Inc. Common Stock
    $22.52
    ▼ 3.31%
    Market cap $650.97MP/E 21.02
    $14.43$37.77
  • BBNX
    Beta Bionics Inc. Common Stock
    $16.35
    ▼ 5.55%
    Market cap $634.80MP/E —
    $8.8$32.71
  • BWAY
    BrainsWay Ltd. American Depositary Shares
    $11.44
    ▼ 3.21%
    Market cap $626.52MP/E 53.55
    $2,391$5,123
  • ANGO
    AngioDynamics Inc. Common Stock
    $11.24
    ▼ 2.94%
    Market cap $624.53MP/E —
    $9.39$16.29

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
1.00M
Disposed
1.10M

Institutional Ownership

March 31, 2026

Total shares held
1.57M
Total value held
$7.27M
Institutional holders
24
Top holders this quarter
  • Unknown833.3K
  • Unknown155.5K
  • Unknown120.0K
  • Unknown116.9K
  • Unknown110.2K
  • Unknown50.0K
  • Unknown38.5K
  • Unknown36.3K
  • Unknown20.6K
  • Unknown18.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.